Research output per year
Research output per year
Personal profile
Research interests
Novel therapies and outcome measures for cystic fibrosis.
Clinical interests
Adult patients with cystic fibrosis clinical outcomes. obstructive lung disease, COPD, pulmonary medicine.
Fingerprint
Dive into the research topics where Daniel Rosenbluth is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Evaluating the impact of stopping chronic therapies after modulator drug therapy in cystic fibrosis: The SIMPLIFY clinical trial study design
Mayer-Hamblett, N., Nichols, D. P., Odem-Davis, K., Riekert, K. A., Sawicki, G. S., Donaldson, S. H., Ratjen, F., Konstan, M. W., Simon, N., Rosenbluth, D. B., Retsch-Bogart, G., Clancy, J. P., Van Dalfsen, J. M., Buckingham, R. & Gifford, A. H., Aug 2021, In: Annals of the American Thoracic Society. 18, 8, p. 1397-1405 9 p.Research output: Contribution to journal › Article › peer-review
Open Access28 Scopus citations -
Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
VX14-661-110 study group, Jul 2021, In: The Lancet Respiratory Medicine. 9, 7, p. 733-746 14 p.Research output: Contribution to journal › Article › peer-review
29 Scopus citations -
Multi-dimensional clinical phenotyping of a national cohort of adult cystic fibrosis patients
Conrad, D. J., Billings, J., Teneback, C., Koff, J., Rosenbluth, D., Bailey, B. A. & Jain, R., Jan 2021, In: Journal of Cystic Fibrosis. 20, 1, p. 91-96 6 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis
on behalf of the Rio-CF Study Group, Nov 2021, In: Journal of Cystic Fibrosis. 20, 6, p. 1018-1025 8 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network
Pearson, K., Mayer-Hamblett, N., Goss, C. H., Retsch-Bogart, G. Z., VanDalfsen, J. M., Burks, P., Rosenbluth, D., Clancy, J. P., Hoffman, A. & Nichols, D. P., Mar 2021, In: Journal of Cystic Fibrosis. 20, 2, p. 195-197 3 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations